These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9597371)

  • 1. Factors influencing preference of insulin regimen in people with type 1 (insulin-dependent) diabetes.
    Perros P; Deary IJ; Frier BM
    Diabetes Res Clin Pract; 1998 Jan; 39(1):23-9. PubMed ID: 9597371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary-care-based analysis.
    Sharplin P; Gordon J; Peters JR; Tetlow AP; Longman AJ; McEwan P
    Cardiovasc Diabetol; 2009 Feb; 8():9. PubMed ID: 19220880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple mealtime administration of biphasic insulin aspart 30 versus traditional basal-bolus human insulin treatment in patients with type 1 diabetes.
    Chen JW; Lauritzen T; Bojesen A; Christiansen JS
    Diabetes Obes Metab; 2006 Nov; 8(6):682-9. PubMed ID: 17026493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape).
    Vora J; Cohen N; Evans M; Hockey A; Speight J; Whately-Smith C
    Diabetes Obes Metab; 2015 Dec; 17(12):1133-41. PubMed ID: 26085028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glargine versus NPH insulin: efficacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes--the glargine and aspart study (GLASS) a randomised cross-over study.
    Chatterjee S; Jarvis-Kay J; Rengarajan T; Lawrence IG; McNally PG; Davies MJ
    Diabetes Res Clin Pract; 2007 Aug; 77(2):215-22. PubMed ID: 17141354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple daily insulin injections improve self-confidence.
    Houtzagers CM; Visser AP; Berntzen PA; van der Stap H; van Maarschalkerweerd WW; Heine RJ; van der Veen EA
    Diabet Med; 1989 Aug; 6(6):512-9. PubMed ID: 2527133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological and demographic correlates of glycaemic control in adult patients with type 1 diabetes.
    Hepburn DA; Langan SJ; Deary IJ; Macleod KM; Frier BM
    Diabet Med; 1994 Jul; 11(6):578-82. PubMed ID: 7955976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
    Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
    Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of injection sites for soluble insulin on glycaemic control in type 1 (insulin-dependent) diabetic patients treated with a multiple insulin injection regimen.
    Henriksen JE; Djurhuus MS; Vaag A; Thye-Rønn P; Knudsen D; Hother-Nielsen O; Beck-Nielsen H
    Diabetologia; 1993 Aug; 36(8):752-8. PubMed ID: 8405743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.
    Skyler JS; Weinstock RS; Raskin P; Yale JF; Barrett E; Gerich JE; Gerstein HC;
    Diabetes Care; 2005 Jul; 28(7):1630-5. PubMed ID: 15983312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of insulin lispro protamine suspension and insulin detemir in basal-bolus therapy in patients with Type 1 diabetes.
    Chacra AR; Kipnes M; Ilag LL; Sarwat S; Giaconia J; Chan J;
    Diabet Med; 2010 May; 27(5):563-9. PubMed ID: 20536953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study.
    Sharplin P; Gordon J; Peters JR; Tetlow AP; Longman AJ; McEwan P
    Cardiovasc Diabetol; 2009 Jan; 8():3. PubMed ID: 19152692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bridge to insulin pump therapy: twice-daily regimen with NPH and detemir insulins during initial treatment of youth with type 1 diabetes mellitus.
    Cengiz E; Sherr JL; Erkin-Cakmak A; Weinzimer SA; Burke EN; Sikes KA; Urban AD; Tamborlane WV
    Endocr Pract; 2011; 17(6):862-6. PubMed ID: 21550949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents.
    Jacober SJ; Scism-Bacon JL; Zagar AJ
    Diabetes Obes Metab; 2006 Jul; 8(4):448-55. PubMed ID: 16776752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycaemic control of insulin-dependent diabetes mellitus in Sudan: influence of insulin shortage.
    Elbagir MN; Eltom MA; Rosling H; Berne C
    Diabetes Res Clin Pract; 1995 Oct; 30(1):43-52. PubMed ID: 8745205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple insulin injection regimen: more dietary freedom without reduced glycated haemoglobin.
    Dorchy H
    Diabetes Res Clin Pract; 1993 May; 20(2):169-70. PubMed ID: 8375270
    [No Abstract]   [Full Text] [Related]  

  • 18. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment.
    Lepore G; Dodesini AR; Nosari I; Trevisan R
    Diabetes Care; 2003 Apr; 26(4):1321-2. PubMed ID: 12663625
    [No Abstract]   [Full Text] [Related]  

  • 19. Audit of the change from twice daily to basal-bolus insulin regimens in insulin-dependent diabetes.
    Baxter MA; Wright AD
    J Diabetes Complications; 1993; 7(1):34-8. PubMed ID: 8481548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen.
    Nielsen FS; Jørgensen LN; Ipsen M; Voldsgaard AI; Parving HH
    Diabetologia; 1995 May; 38(5):592-8. PubMed ID: 7489843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.